Inventor
BENTLEY JONATHAN MARK
GB19 patents
⚠️ This page may combine multiple inventors who share the name “BENTLEY JONATHAN MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERNALIS RES LTD
8 patentsUS6706750B1Mar 16, 2004
Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application
VERNALIS RES LTD68 citations95
US6433175B1Aug 13, 2002
Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
VERNALIS RES LTD32 citations91
US6380238B1Apr 30, 2002
Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands
VERNALIS RES LTD27 citations90
US6552062B1Apr 22, 2003
Indazole derivatives with 5-HT2 receptor activity
VERNALIS RES LTD13 citations82
US6365598B1Apr 2, 2002
Pyrroloquinolines for treatment of obesity
VERNALIS RES LTD15 citations82
US7253281B2Aug 7, 2007
Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
VERNALIS RES LTD3 citations63
US6933387B2Aug 23, 2005
Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
VERNALIS RES LTD4 citations63
US7098337B2Aug 29, 2006
1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives
VERNALIS RES LTD0 citations40
HOFFMANN LA ROCHE
5 patentsUS6479534B1Nov 12, 2002
Indoline derivatives and method of treating obesity
HOFFMANN LA ROCHE19 citations82
US6583134B2Jun 24, 2003
Aza- indolyl derivatives for treating obesity
HOFFMANN LA ROCHE10 citations73
US6610685B2Aug 26, 2003
Fused indole derivatives
HOFFMANN LA ROCHE11 citations70
US7323466B2Jan 29, 2008
Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity
HOFFMANN LA ROCHE1 citations48
US7022707B2Apr 4, 2006
Piperazine derivatives
HOFFMANN LA ROCHE0 citations40
UCB BIOPHARMA SPRL
3 patentsUS9868749B2Jan 16, 2018
Fused imidazole and pyrazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL16 citations81
US9475820B2Oct 25, 2016
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators
UCB BIOPHARMA SPRL3 citations70
US9309243B2Apr 12, 2016
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL4 citations68